Chinese pharma giant Shanghai Pharmaceuticals is in talks with major Indian pharmaceutical companies for greater access to ...

STEERlife and Callidus Research Laboratories join forces to accelerate drug development for global markets, combining hot melt extrusion and pharmaceutical expertise.

Joint efforts promise innovative drug solutions and enhanced offerings while enabling comprehensive development of active ...

Invizyne is redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform ...

The Canadian market, like its U.S. counterpart, has been experiencing a notable upswing following the recent decisive election outcome in the United States, which has cleared a significant source of ...

In the past, we used to export a lot of APIs (Active Pharmaceutical Ingredients) and in the mid chemical products (sector) to ...

Shanghai: Li Dongming, Vice President of Shanghai Pharmaceuticals, expressed hope on Tuesday for more investment from Indian ...

Invizyne is redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals, such as ...

Detailed price information for Cosciens Biopharma Inc (CSCI-T) from The Globe and Mail including charting and trades.

Y-o-Y Growth and Strong Performance in 2024 The Small Molecule API market is anticipated to exhibit a Y-o-Y growth of 4.6% in ...

Industry experts from across 100 countries will descend on Riyadh this December for launch event of most comprehensive pharma ...

Speaking on Tuesday, Li expressed hopes of co-developing products with Indian companies for global markets, highlighting past ...